NASDAQ-100 undervalued ranking
Ranked by the GARP strategy. Lower valuation ranks higher. · Healthcare
Data as of: 2026-10-30 · end-of-day, not real-time
Information & education only — not investment advice or a guarantee of returns.
Best Undervalued NASDAQ-100 Stocks (2026) →
Best Balanced NASDAQ-100 Stocks (2026) →
💡 Preset screens
GARP — Growth at a reasonable price (low PEG)
Built from: PEG · Forward P/E · Earnings Growth
Details →7 stocks · 2 value-trap stocks hidden
Return periodtrading days (holidays excluded)
Sort
1Regeneron PharmaceuticalsREGN NASDAQ · HealthcareP/E22.954.1
💊 Bio/vaccine
Mkt Cap
$95.5B
P/E
22.9
P/B
3.0
1M
+26.2%
2GE HealthCareGEHC NASDAQ · HealthcareP/E16.253.2①
Mkt Cap
$34.6B
P/E
16.2
P/B
3.0
1M
+19.2%
3DexComDXCM NASDAQ · HealthcareP/E32.748.4①
Mkt Cap
$31.1B
P/E
32.7
P/B
11.5
1M
-3.6%
4Gilead SciencesGILD NASDAQ · HealthcareP/E–39.4①
Mkt Cap
$211.8B
P/E
–
P/B
9.3
1M
+17.9%
5AmgenAMGN NASDAQ · HealthcareP/E28.938.4
Mkt Cap
$251.9B
P/E
28.9
P/B
21.6
1M
+15.6%
6Vertex PharmaceuticalsVRTX NASDAQ · HealthcareP/E32.527.4
Mkt Cap
$141.7B
P/E
32.5
P/B
7.0
1M
+10.7%
7Idexx LaboratoriesIDXX NASDAQ · HealthcareP/E38.718.6
Mkt Cap
$43.4B
P/E
38.7
P/B
27.0
1M
+6.3%